A mouse for the war on cancer

May 1994
U.S. News & World Report;5/9/94, Vol. 116 Issue 18, p18
Discusses the HuMAb-Mouse from GenPharm International and Cell Genesys' Xenomouse, two bioengineered rodents. Thanks to crossbreeding and laboratory maneuvers, both mouse strains carry a key piece of the human immune system: the machinery for making molecules called antibodies that help the body fight off foreign invaders such a bacteria. Hopes that scientists can grow vast amounts of mouse-produced antibodies to fight diseases like cancer.


Related Articles

  • A simple model system to demonstrate antibody structure and functions. O'Kennedy, Richard // Journal of Biological Education (Society of Biology);Spring91, Vol. 25 Issue 1, p5 

    Details the design and construction of a model to illustrate fragments, single domain and bifunctional antibodies. Immunoglobulins as an integral part of the immune system; Use of antibodies in a whole range of different analytical methods; Reduction of antibodies to a number of fragments either...

  • Pneumococcal Carriage and Otitis Media Induce Salivary Antibodies.  // Journal of Infectious Diseases;3/15/2001, Vol. 183 Issue 6, p887 

    Reports on a study of pneumococcal carriage and otitis media induce salivary antibodies to penumococcal surface adhesin A, pneumolysin, and pneumococcal surface protein A in children.

  • CORRECTION.  // Journal of Clinical Pathology;May2008, Vol. 61 Issue 5, p688 

    A correction to the article "The Clinical Significance of Antinucleolar Antibodies," by S. Khan, A. Alvi, S. Holding et al., in the March 2008 issue is presented.

  • Visualising the immune repertoire. Mollova, Svetlana; Retter, Ida; Müller1, Werner // BMC Systems Biology;2007 Supplement 1, Vol. 1, pP30 

    An abstract of the article "Visualising the immune repertoire," by Svetlana Mollova, Ida Retter and Werner Müller is presented.

  • Immune globulin.  // Reactions Weekly;6/12/2010, Issue 1305, p18 

    The article describes the case of a 71-year-old woman with a record of hypertension, chronic kidney disease and congenital heart failure who experienced acute renal failure after taking immune globulin for treatment of pyoderma gangrenosum.

  • Erratum: Polyclonal antibodies step out of the shadows. Waltz, Emily // Nature Biotechnology;Nov2006, Vol. 24 Issue 11, p1448 

    A correction to the article "Polyclonal antibodies step out of the shadows" that was published in the November 8, 2006 issue is presented.

  • CORRECTION: Therapeutic antibodies for human disease at the dawn of the twenty-first century. Brekke, Ole Henrik; Sandlie, Inger // Nature Reviews Drug Discovery;Mar2003, Vol. 2 Issue 3, p240 

    Presents a correct reprint of an article about therapeutic antibodies for human disease previously published in the periodical 'Nature Reviews Drug Discovery.'

  • ERRATUM.  // Journal of Infectious Diseases;3/1/2009, Vol. 199 Issue 5, p770 

    A correction to the article "Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults" in the December 15, 2008 issue is presented.

  • Programming antibodies for novel applications. Dübel, S. // Chemie Ingenieur Technik (CIT);Sep2018, Vol. 90 Issue 9, p1248 

    No abstract available.


Read the Article

Other Topics